Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity

PA Flume, JD Chalmers, KN Olivier - The Lancet, 2018 - thelancet.com
Bronchiectasis is characterised by pathological dilation of the airways. More specifically, the
radiographic demonstration of airway enlargement is the common feature of a …

[HTML][HTML] Signalling by transforming growth factor beta isoforms in wound healing and tissue regeneration

RWD Gilbert, MK Vickaryous… - Journal of developmental …, 2016 - mdpi.com
Transforming growth factor beta (TGFβ) signalling is essential for wound healing, including
both non-specific scar formation and tissue-specific regeneration. Specific TGFβ isoforms …

Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms

A Nyström, K Thriene, V Mittapalli, JS Kern… - EMBO molecular …, 2015 - embopress.org
Genetic loss of collagen VII causes recessive dystrophic epidermolysis bullosa (RDEB)—a
severe skin fragility disorder associated with lifelong blistering and disabling progressive …

Marfan syndrome: current perspectives

G Pepe, B Giusti, E Sticchi, R Abbate… - The application of …, 2016 - Taylor & Francis
Marfan syndrome (MFS) is a pleiotropic connective tissue disease inherited as an autosomal
dominant trait, due to mutations in the FBN1 gene encoding fibrillin 1. It is an important …

A mutation update on the LDS‐associated genes TGFB2/3 and SMAD2/3

D Schepers, G Tortora, H Morisaki… - Human …, 2018 - Wiley Online Library
Abstract The Loeys–Dietz syndrome (LDS) is a connective tissue disorder affecting the
cardiovascular, skeletal, and ocular system. Most typically, LDS patients present with aortic …

Management of primary and secondary osteoporosis in children

SD Sakka, MS Cheung - Therapeutic Advances in …, 2020 - journals.sagepub.com
Osteoporosis in children differs from adults in terms of definition, diagnosis, monitoring and
treatment options. Primary osteoporosis comprises primarily of osteogenesis imperfecta (OI) …

The TGF-β pathway plays a key role in aortic aneurysms

T Tingting, F Wenjing, Z Qian, W Hengquan, Z Simin… - Clinica chimica acta, 2020 - Elsevier
Aortic dissection and aortic aneurysms are currently among the most high-risk
cardiovascular diseases due to their rapid onset and high mortality. Although aneurysm …

A perspective on implementing a quantitative systems pharmacology platform for drug discovery and the advancement of personalized medicine

AM Stern, ME Schurdak, I Bahar… - Journal of …, 2016 - journals.sagepub.com
Drug candidates exhibiting well-defined pharmacokinetic and pharmacodynamic profiles
that are otherwise safe often fail to demonstrate proof-of-concept in phase II and III trials …

An exploration of alternative therapeutic targets for aortic disease in Marfan syndrome

LJF Van Den Heuvel, S Peeters, JAN Meester… - Drug Discovery …, 2024 - Elsevier
Highlights•No medical intervention can completely arrest aneurysmal growth.•Drugs with
immediate translational potential in Marfan syndrome include resveratrol, doxycycline …

[HTML][HTML] Precise therapy for thoracic aortic aneurysm in marfan syndrome: a puzzle nearing its solution

E Rurali, GL Perrucci, CA Pilato, A Pini… - Progress in …, 2018 - Elsevier
Marfan Syndrome (MFS) is a rare connective tissue disorder, resulting from mutations in the
fibrillin-1 gene, characterized by pathologic phenotypes in multiple organs, the most …